Brief: Entrada Closes Agreement With Vertex For Endosomal Escape Vehicle-Therapeutics for Myotonic Dystrophy Type 1 (DM1)
09/02/2023 13:20
Feb 9 (Reuters) - Entrada Therapeutics Inc TRDA.O :
* ENTRADA THERAPEUTICS CLOSES AGREEMENT WITH VERTEX TO
DISCOVER
AND DEVELOP ENDOSOMAL ESCAPE VEHICLE-THERAPEUTICS FOR MYOTONIC
DYSTROPHY TYPE 1 (DM1)
* ENTRADA THERAPEUTICS INC - COMPANY'S CASH RUNWAY EXTENDED
INTO
SECOND HALF OF 2025
Source text for Eikon: ID:nGNX7rk0Yd
Further company coverage: TRDA.O
Recent news on Entrada Therapeutics
See all newsBrief: Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Entrada Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Entrada Therapeutics Q2 Collaboration Revenue USD 898 Thousand
Entrada Therapeutics Q2 net loss narrows on lower costs
Entrada Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview